The main beneficiaries of the jab developed in the U.S. are likely to be women with a very early form of breast cancer called ductal carcinoma in situ, or DCIS.
from Health | Mail Online http://www.dailymail.co.uk/health/article-2532301/Breast-cancer-jab-prevents-disease-75-cases-Treatment-spare-thousands-women-trauma-surgery.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490
via dailymail
from Health | Mail Online http://www.dailymail.co.uk/health/article-2532301/Breast-cancer-jab-prevents-disease-75-cases-Treatment-spare-thousands-women-trauma-surgery.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490
via dailymail
No comments:
Post a Comment